| Evaluation of endogenous metabolic markers of hepatic CYP3A activity using metabolic profiling and midazolam clearance KH Shin, MH Choi, KS Lim, KS Yu, IJ Jang, JY Cho Clinical pharmacology & therapeutics 94 (5), 601-609, 2013 | 127 | 2013 |
| Reduced valproic acid serum concentrations due to drug interactions with carbapenem antibiotics: overview of 6 cases MK Park, KS Lim, TE Kim, HK Han, SJ Yi, KH Shin, JY Cho, SG Shin, ... Therapeutic drug monitoring 34 (5), 599-603, 2012 | 77 | 2012 |
| Pharmacokinetics, pharmacodynamics, and tolerability of the dipeptidyl peptidase IV inhibitor LC15-0444 in healthy Korean men: a dose—block-randomized, double-blind, placebo … KS Lim, JR Kim, YJ Choi, KH Shin, KP Kim, JH Hong, JY Cho, HS Shin, ... Clinical therapeutics 30 (10), 1817-1830, 2008 | 52 | 2008 |
| Tolerability and pharmacokinetics of lobeglitazone (CKD-501), a peroxisome proliferator-activated receptor-γ agonist: a single-and multiple-dose, double-blind, randomized … JW Kim, JR Kim, SJ Yi, KH Shin, HS Shin, SH Yoon, JY Cho, DH Kim, ... Clinical therapeutics 33 (11), 1819-1830, 2011 | 46 | 2011 |
| Effect of green tea catechins on the pharmacokinetics of digoxin in humans TE Kim, KH Shin, JE Park, MG Kim, YM Yun, DH Choi, KJ Kwon, J Lee Drug Design, Development and Therapy, 2139-2147, 2018 | 42 | 2018 |
| Urinary 6β-hydroxycortisol/cortisol ratio most highly correlates with midazolam clearance under hepatic CYP3A inhibition and induction in females: a pharmacometabolomics approach KH Shin, LY Ahn, MH Choi, JY Moon, J Lee, IJ Jang, KS Yu, JY Cho The AAPS journal 18, 1254-1261, 2016 | 41 | 2016 |
| The effect of the newly developed angiotensin receptor II antagonist fimasartan on the pharmacokinetics of atorvastatin in relation to OATP1B1 in healthy male volunteers KH Shin, TE Kim, SE Kim, MG Lee, IS Song, SH Yoon, JY Cho, IJ Jang, ... Journal of Cardiovascular Pharmacology 58 (5), 492-499, 2011 | 40 | 2011 |
| Metabolite changes in risk of type 2 diabetes mellitus in cohort studies: A systematic review and meta-analysis JE Park, HR Lim, JW Kim, KH Shin Diabetes research and clinical practice 140, 216-227, 2018 | 36 | 2018 |
| Exploration of biomarkers for amoxicillin/clavulanate‐induced liver injury: multi‐omics approaches J Lee, SC Ji, B Kim, S Yi, KH Shin, JY Cho, KS Lim, SH Lee, SH Yoon, ... Clinical and translational science 10 (3), 163-171, 2017 | 36 | 2017 |
| Aspirin decreases systemic exposure to clopidogrel through modulation of P‐glycoprotein but does not alter its antithrombotic activity J Oh, D Shin, KS Lim, S Lee, KH Jung, K Chu, KS Hong, KH Shin, JY Cho, ... Clinical Pharmacology & Therapeutics 95 (6), 608-616, 2014 | 32 | 2014 |
| Trough concentration over 12.1 mg/L is a major risk factor of vancomycin-related nephrotoxicity in patients with therapeutic drug monitoring HK Han, H An, KH Shin, D Shin, SH Lee, JH Kim, SH Cho, HR Kang, ... Therapeutic drug monitoring 36 (5), 606-611, 2014 | 30 | 2014 |
| Assessment of the drug–drug interactions between fimasartan and hydrochlorothiazide in healthy volunteers H Jeon, KS Lim, KH Shin, JW Kim, SH Yoon, JY Cho, SG Shin, IJ Jang, ... Journal of Cardiovascular Pharmacology 59 (1), 84-91, 2012 | 29 | 2012 |
| A pharmacometabolomic approach to predict response to metformin in early-phase type 2 diabetes mellitus patients JE Park, GH Jeong, IK Lee, YR Yoon, KH Liu, N Gu, KH Shin Molecules 23 (7), 1579, 2018 | 26 | 2018 |
| Quantitative analysis of four catechins from green tea extract in human plasma using ultra-performance liquid chromatography-tandem mass spectrometry for pharmacokinetic studies JE Park, TE Kim, KH Shin Molecules 23 (4), 984, 2018 | 20 | 2018 |
| Comparison of pharmacokinetics between new quinolone antibiotics: the zabofloxacin hydrochloride capsule and the zabofloxacin aspartate tablet HK Han, SE Kim, KH Shin, C Lim, KS Lim, KS Yu, JY Cho Current medical research and opinion 29 (10), 1349-1355, 2013 | 20 | 2013 |
| The effects of ketoconazole and rifampicin on the pharmacokinetics of mirodenafil in healthy Korean male volunteers: an open-label, one-sequence, three-period, three-treatment … KH Shin, BH Kim, TE Kim, JW Kim, SJ Yi, SH Yoon, JY Cho, SG Shin, ... Clinical therapeutics 31 (12), 3009-3020, 2009 | 20 | 2009 |
| Pharmacokinetic comparison of a new glimepiride 1-mg+ metformin 500-mg combination tablet formulation and a glimepiride 2-mg+ metformin 500-mg combination tablet formulation: a … BH Kim, KH Shin, JW Kim, KS Lim, K Kim, JR Kim, JY Cho, SG Shin, ... Clinical therapeutics 31 (11), 2755-2764, 2009 | 20 | 2009 |
| Bioanalytical method using ultra-high-performance liquid chromatography coupled with high-resolution mass spectrometry (UHPL-CHRMS) for the detection of metformin in human plasma YJ Kang, HC Jeong, TE Kim, KH Shin Molecules 25 (20), 4625, 2020 | 19 | 2020 |
| Population pharmacokinetic analysis of tramadol and O-desmethyltramadol with genetic polymorphism of CYP2D6 J Lee, HD Yoo, JW Bae, S Lee, KH Shin Drug design, development and therapy, 1751-1761, 2019 | 18 | 2019 |
| Metabolite signature associated with stress susceptibility in socially defeated mice VV Prabhu, TB Nguyen, Y Cui, YE Oh, YH Piao, HM Baek, JY Kim, ... Brain Research 1708, 171-180, 2019 | 18 | 2019 |
